Doctor profile · Federal record
Dr. Saad Usmani, MD
Internal Medicine Physician (CMS: Hematopoietic Cell Transplantation and Cellular Therapy) · Charlotte, NC
- NPI 1962601526
- Accepts Medicare
- MIPS 74.0 / 100 · 2023
- 24 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
1021 Morehead Medical Dr, Ste A
Charlotte, NC 282042990
(980) 442-2000 - Additional location
-
10660 Park RD, Ste 2100
Charlotte, NC 282108413
(980) 442-0410 - Additional location
-
16455 Statesville RD, Ste 280
Huntersville, NC 280787135
(980) 442-4600 - Mailing address
-
Po Box 19305
Charlotte, NC 282199305
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- January 5, 2022
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207R00000X — NUCC code
- State license (1)
- North Carolina #2013-01066
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1962601526. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
388
Distinct HCPCS
3
Medicare allowed
$60,131
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 312 | 103 | $160 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 45 | 45 | $202 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 31 | 23 | $35 |
In context: peer comparison
Among 187 peers in Charlotte Internal Medicine Physician, average services per provider: 102. This provider delivers 3.8× the peer median.Open Payments
Industry payments received
All-time total
$74,512
Transactions
69
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $14,000.00 | |
| Janssen Global Services, LLC | 12 | $11,517.60 | |
| Genzyme Corporation | 6 | $10,340.15 | |
| Pfizer INC. | 8 | $9,534.05 | |
| Regeneron Pharmaceuticals, INC. | 4 | $5,981.18 | |
| Janssen Research & Development, LLC | 4 | $5,715.00 | |
| Janssen Biotech, INC. | 10 | $4,943.07 | |
| AstraZeneca Pharmaceuticals Lp | 6 | $3,701.82 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $3,342.50 | |
| Legend Biotech USA INC. | 4 | $2,499.40 | |
| F. Hoffmann-la Roche Ag | 3 | $1,491.83 | |
| The Binding Site INC. | 1 | $1,000.00 | |
| Celgene Corporation | 5 | $400.04 | |
| Janssen Scientific Affairs, LLC | 2 | $45.04 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
290
Patients
49
Total drug cost
$898,423
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Acyclovir | Generic | 134 | 37 | $1,958 |
| Xarelto (Rivaroxaban) | Brand | 47 | 0 | $33,091 |
| Revlimid (Lenalidomide) | Brand | 40 | 12 | $655,566 |
| Omeprazole | Generic | 20 | 0 | $345 |
| Dexamethasone | Generic | 17 | 0 | $304 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 17 | 0 | $102 |
| Lenalidomide | Generic | 15 | 0 | $207,056 |
Frequently asked questions
What is Dr. Saad Usmani's medical specialty?
Dr. Saad Usmani practices Internal Medicine Physician in Charlotte, NC.
Where does Dr. Saad Usmani practice?
Dr. Saad Usmani practices at 1021 Morehead Medical Dr, Charlotte, NC 282042990. Office phone: 9804422000.
What is Dr. Saad Usmani's NPI?
Dr. Saad Usmani's National Provider Identifier (NPI) is 1962601526, issued by NPPES.
Does Dr. Saad Usmani accept Medicare assignment?
Yes. Dr. Saad Usmani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Saad Usmani commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99205); Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS G2212). Source: CMS Medicare Physician & Other Practitioners file.